290 related articles for article (PubMed ID: 38370347)
1. Neurotoxicity-sparing radiotherapy for brain metastases in breast cancer: a narrative review.
Buczek D; Zaucha R; Jassem J
Front Oncol; 2023; 13():1215426. PubMed ID: 38370347
[TBL] [Abstract][Full Text] [Related]
2. Current approaches to the management of brain metastases.
Suh JH; Kotecha R; Chao ST; Ahluwalia MS; Sahgal A; Chang EL
Nat Rev Clin Oncol; 2020 May; 17(5):279-299. PubMed ID: 32080373
[TBL] [Abstract][Full Text] [Related]
3. Management of brain metastases in breast cancer: a review of current practices and emerging treatments.
Mills MN; Figura NB; Arrington JA; Yu HM; Etame AB; Vogelbaum MA; Soliman H; Czerniecki BJ; Forsyth PA; Han HS; Ahmed KA
Breast Cancer Res Treat; 2020 Apr; 180(2):279-300. PubMed ID: 32030570
[TBL] [Abstract][Full Text] [Related]
4. Glial activation positron emission tomography imaging in radiation treatment of breast cancer brain metastases.
Badiuk SR; Thiessen JD; Maleki Vareki S; Foster PJ; Chen JZ; Wong E
Phys Imaging Radiat Oncol; 2022 Jan; 21():115-122. PubMed ID: 35359488
[TBL] [Abstract][Full Text] [Related]
5. Emerging treatment strategies for breast cancer brain metastasis: from translational therapeutics to real-world experience.
Ren D; Cheng H; Wang X; Vishnoi M; Teh BS; Rostomily R; Chang J; Wong ST; Zhao H
Ther Adv Med Oncol; 2020; 12():1758835920936151. PubMed ID: 32655700
[TBL] [Abstract][Full Text] [Related]
6. Breast Cancer Brain Metastasis: A Comprehensive Review.
Raghavendra AS; Ibrahim NK
JCO Oncol Pract; 2024 May; ():OP2300794. PubMed ID: 38748968
[TBL] [Abstract][Full Text] [Related]
7. Capecitabine and stereotactic radiation in the management of breast cancer brain metastases.
Mills MN; Naz A; Thawani C; Walker C; Figura NB; Kushchayev S; Oliver DE; Etame AB; Yu HM; Robinson TJ; Liu JKC; Vogelbaum MA; Forsyth PA; Czerniecki BJ; Soliman HH; Han HS; Ahmed KA
BMC Cancer; 2021 May; 21(1):552. PubMed ID: 33992087
[TBL] [Abstract][Full Text] [Related]
8. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
Lunsford LD; Flickinger JC; Larson D
Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
[TBL] [Abstract][Full Text] [Related]
9. A Multidisciplinary Breast Cancer Brain Metastases Clinic: The University of North Carolina Experience.
McKee MJ; Keith K; Deal AM; Garrett AL; Wheless AA; Green RL; Benbow JM; Dees EC; Carey LA; Ewend MG; Anders CK; Zagar TM
Oncologist; 2016 Jan; 21(1):16-20. PubMed ID: 26659221
[TBL] [Abstract][Full Text] [Related]
10. Management of breast cancer brain metastases: Focus on human epidermal growth factor receptor 2-positive breast cancer.
Yuan P; Gao SL
Chronic Dis Transl Med; 2017 Mar; 3(1):21-32. PubMed ID: 29063053
[TBL] [Abstract][Full Text] [Related]
11. Outcome and prognostic value of treatment for brain metastases and the primary tumor in patients with breast cancer brain metastases.
Wang Y; Ji Z; Lin FH; Wang XH; Wan-Ming H; He ZQ; Duan H; Guo CC; Zhang XH; Mou YG
Clin Neurol Neurosurg; 2018 Jul; 170():43-46. PubMed ID: 29727800
[TBL] [Abstract][Full Text] [Related]
12. Survival after surgery and stereotactic radiosurgery for patients with multiple intracranial metastases: results of a single-center retrospective study.
Smith TR; Lall RR; Lall RR; Abecassis IJ; Arnaout OM; Marymont MH; Swanson KR; Chandler JP
J Neurosurg; 2014 Oct; 121(4):839-45. PubMed ID: 24857242
[TBL] [Abstract][Full Text] [Related]
13. Treatment strategies for breast cancer brain metastases.
Bailleux C; Eberst L; Bachelot T
Br J Cancer; 2021 Jan; 124(1):142-155. PubMed ID: 33250512
[TBL] [Abstract][Full Text] [Related]
14. Advances in Radiotherapy for Brain Metastases.
Matsui JK; Perlow HK; Upadhyay R; McCalla A; Raval RR; Thomas EM; Blakaj DM; Beyer SJ; Palmer JD
Surg Oncol Clin N Am; 2023 Jul; 32(3):569-586. PubMed ID: 37182993
[TBL] [Abstract][Full Text] [Related]
15. Bisphosphonates and other bone agents for breast cancer.
Wong MH; Stockler MR; Pavlakis N
Cochrane Database Syst Rev; 2012 Feb; (2):CD003474. PubMed ID: 22336790
[TBL] [Abstract][Full Text] [Related]
16. Surgery versus stereotactic radiotherapy for people with single or solitary brain metastasis.
Fuentes R; Osorio D; Expósito Hernandez J; Simancas-Racines D; Martinez-Zapata MJ; Bonfill Cosp X
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012086. PubMed ID: 30125049
[TBL] [Abstract][Full Text] [Related]
17. Trastuzumab Emtansine (T-DM1) and stereotactic radiation in the management of HER2+ breast cancer brain metastases.
Mills MN; Walker C; Thawani C; Naz A; Figura NB; Kushchayev S; Etame A; Yu HM; Robinson TJ; Liu J; Vogelbaum MA; Forsyth PA; Czerniecki BJ; Soliman HH; Han HS; Ahmed KA
BMC Cancer; 2021 Mar; 21(1):223. PubMed ID: 33663447
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer brain metastases: Molecular subtype, treatment and survival.
Crozier JA; Cornell LF; Rawal B; Perez EA
Breast Dis; 2016; 36(4):133-141. PubMed ID: 27802190
[TBL] [Abstract][Full Text] [Related]
19. Novel models by machine learning to predict prognosis of breast cancer brain metastases.
Li C; Liu M; Zhang Y; Wang Y; Li J; Sun S; Liu X; Wu H; Feng C; Yao P; Jia Y; Zhang Y; Wei X; Wu F; Du C; Zhao X; Zhang S; Qu J
J Transl Med; 2023 Jun; 21(1):404. PubMed ID: 37344847
[TBL] [Abstract][Full Text] [Related]
20. LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases.
Van Swearingen AED; Siegel MB; Deal AM; Sambade MJ; Hoyle A; Hayes DN; Jo H; Little P; Dees EC; Muss H; Jolly T; Zagar TM; Patel N; Miller CR; Parker JS; Smith JK; Fisher J; Shah N; Nabell L; Nanda R; Dillon P; Abramson V; Carey LA; Anders CK
Breast Cancer Res Treat; 2018 Oct; 171(3):637-648. PubMed ID: 29938395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]